Renal Function in Patients With Cadaveric Kidney Transplants Treated With Tacrolimus or Cyclosporine

Transplantation Proceedings

Volumn 39, Issue 7, 2007, Pages 2167-2169

  Gonzalez Molina, M ^a   Morales, J M ^a   Marcen, R ^a   Campistol, J M ^a   Oppenheimer, F ^a   Seron D ^a   Gil Vernet, S ^a   Capdevila, L ^a   Andres A ^a   Lampreave, I ^a   Del Castillo, D ^a   Cabello, M ^a   Burgos, D ^a   Valdes F ^a   Anaya, F ^a   Escuin F ^a   Arias, M ^a   Pallardo L ^a   Bustamante, J ^a  

^a Department of Nephrology   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; TACROLIMUS;

ADULT; ARTICLE; CADAVER KIDNEY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DRUG DOSE REDUCTION; DRUG EFFICACY; FEMALE; GLOMERULUS FILTRATION RATE; GRAFT REJECTION; GRAFT SURVIVAL; GRAFT VERSUS HOST REACTION; HUMAN; KIDNEY FUNCTION; KIDNEY GRAFT; LEUKOPENIA; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ADULT; AGED; CADAVER; CYCLOSPORINE; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY FUNCTION TESTS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; TACROLIMUS; TISSUE DONORS;

EID: 34548764941     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2007.07.043     Document Type: Article

References (10)

1. Hariharan S., McBride M.A., Cherikh W.S., et al. Post-transplant renal function in the first year predicts long-term kidney transplant survival. Kidney Int 62 (2002) 311
2. Meier-Kriesche H.U., Steffen B.J., Hochberg A.L., et al. Mycophenolate mofetil versus azathioprine therapy is associated with a significant protection against long-term renal allograft function deterioration. Transplantation 75 (2003) 1341
3. Nankivell B.J., Borrows R.J., Fung C.L.S., et al. The natural history of chronic allograft nephropathy. N Engl J Med 349 (2005) 24
4. Ojo A.O., Held P.J., Port F.K., et al. Chronic renal failure after transplantation of a nonrenal organ. N Engl J Med 349 (2003) 931
5. Meier-Kriesche H.U., Li S., Gruessner R.W.G., et al. Immunosuppression: evolution in practice and trends, 1994-2004. Am J Transplant 6 part 2 (2006) 1111
6. Larsen K. Creatinine assay by a reaction-kinetic approach. Clin Chem Acta 41 (1972) 209
7. Cockcroft D.W., and Gault M.H. Prediction of creatinine clearance from serum creatinine. Nephron 16 (1976) 31
8. Ekberg H., Tedesco-Silva H., Demirbas A., et al. Symphony-comparing standard immunosuppression to low-dose cyclosporine, tacrolimus or sirolimus in combination with MMF, daclizumab and corticosteroids in renal transplantation. WTC. Supplement to Am J Transplant and Transplantation (2006) (abstract 49), page 83
9. Nankivell B.J., Borrows R.J., Fung C.L.S., et al. Natural history, risk factors, and impact of subclinical rejection in kidney transplantation. Transplantation 78 (2004) 242
10. Solez K., Vincenti F., and Filo R.S. Histopathological findings from 2-year protocol biopsies from a U. S. multicenter kidney transplant trial comparing tacrolimus versus cyclosporine: a report of the FK506 Kidney Transplant Study Group. Transplantation 66 (1998) 1736